Abcam PLC
LSE:ABC
Abcam PLC
LSE:ABC
Price:
1 226 GBX
11.15%
Market Closed
Updated:
May 15, 2024
Abcam PLC
Cost of Revenue
|
Abcam PLC
Cost of Revenue Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abcam PLC
LSE:ABC
|
Cost of Revenue
-£95.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-12%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cost of Revenue
-£1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abcam PLC's Cost of Revenue?
Cost of Revenue
-95.7m
GBP
-95.7m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Cost of Revenue amounts to -95.7m GBP.
What is Abcam PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-12%
-12%
Over the last year, the Cost of Revenue growth was -11%. The average annual Cost of Revenue growth rates for Abcam PLC have been -8% over the past three years , -8% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
